Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?

about

Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?

Item

http://www.wikidata.org/entity/Q39506959

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Does the intraocular pressure- ...... s continue over the long term?

@en

Does the intraocular pressure- ...... s continue over the long term?

@nl

type

Item

label

Does the intraocular pressure- ...... s continue over the long term?

@en

Does the intraocular pressure- ...... s continue over the long term?

@nl

prefLabel

Does the intraocular pressure- ...... s continue over the long term?

@en

Does the intraocular pressure- ...... s continue over the long term?

@nl

P1476

Does the intraocular pressure- ...... s continue over the long term?

@en

P2093

Emine Malkoç Şen

http://www.w3.org/2001/XMLSchema#string

Kadriye Ufuk Elgin

http://www.w3.org/2001/XMLSchema#string

Kurtuluş Serdar

http://www.w3.org/2001/XMLSchema#string

Pelin Yilmazbaş

http://www.w3.org/2001/XMLSchema#string

P2860

Hospital Episode Statistics and changing trends in glaucoma surgery.

Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients.

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.

VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness.

Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

A systematic review of the characteristics of randomised control trials featuring prostaglandins for the treatment of glaucoma.

Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.

Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.

P2888

s10792-016-0315-3

P304

619-626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10792-016-0315-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Caner Kara

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27506567

http://www.w3.org/2001/XMLSchema#string